Malignant Pleural Mesothelioma: Diagnosis, Staging, Pitfalls and Follow-up

被引:8
|
作者
Odisio, Erika G. [1 ]
Marom, Edith M. [2 ,3 ]
Shroff, Girish S. [1 ]
Wu, Carol C. [1 ]
Benveniste, Ana Paula A. [4 ]
Truong, Mylene T. [1 ]
Benveniste, Marcelo F. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Unit 1478,1515 Holcombe Blvd, Houston, TX 77030 USA
[2] Chaim Sheba Med Ctr, Dept Diagnost Imaging, Ramat Gan, Israel
[3] Tel Aviv Univ, Tel Aviv, Israel
[4] Baylor Coll Med, Dept Diagnost Radiol, Houston, TX 77030 USA
关键词
EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; FORTHCOMING 8TH EDITION; COMPUTED-TOMOGRAPHY; EXTRAPLEURAL PNEUMONECTOMY; TNM CLASSIFICATION; IASLC MESOTHELIOMA; PROJECT PROPOSALS; SOLID TUMORS; CT; MANAGEMENT;
D O I
10.1053/j.sult.2017.07.006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Malignant pleural mesothelioma Is the most common primary neoplasm of the pleura. Imaging evaluation is essential in diagnosis, staging, and assessment of treatment response in malignant pleural mesothelioma. Computed tomography is the most commonly used modality for tumor staging. Assessment of tumor extension and lymph node involvement is essential in imaging evaluation as locally advanced tumors are amenable to resection. Knowledge of the full imaging spectrum of this rare disease, differential diagnosis, staging classification, and the current guidelines for diagnostic evaluation and follow-up are essential in accurate interpretation to optimize patient management. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:559 / 570
页数:12
相关论文
共 50 条
  • [1] Malignant pleural mesothelioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Stahel, R. A.
    Weder, W.
    Felip, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 43 - 44
  • [2] Malignant pleural mesothelioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Stahel, R. A.
    Weder, W.
    Felip, E.
    ANNALS OF ONCOLOGY, 2009, 20 : 73 - 75
  • [3] Malignant pleural mesothelioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Manegold, C.
    ANNALS OF ONCOLOGY, 2007, 18 : 34 - 35
  • [4] Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant pleural mesothelioma
    Manegold, C
    Stahel, RA
    ANNALS OF ONCOLOGY, 2005, 16 : 32 - 33
  • [5] Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Popat, S.
    Baas, P.
    Faivre-Finn, C.
    Girard, N.
    Nicholson, A. G.
    Nowak, A. K.
    Opitz, I.
    Scherpereel, A.
    Reck, M.
    ANNALS OF ONCOLOGY, 2022, 33 (02) : 129 - 142
  • [6] Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Stahel, R. A.
    Weder, W.
    Lievens, Y.
    Felip, E.
    ANNALS OF ONCOLOGY, 2010, 21 : v126 - v128
  • [7] Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients
    Ak, Guntulu
    Metintas, Muzaffer
    Yildirim, Huseyin
    Metintas, Selma
    Dundar, Emine
    Erginel, Sinan
    Alatas, Fusun
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2009, 57 (01): : 22 - 31
  • [8] Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients
    Ak, G.
    Metintas, M.
    Yildirim, H.
    Erginel, S.
    Alatas, F.
    Metintas, S.
    Dundar, E.
    LUNG CANCER, 2006, 54 : S17 - S17
  • [9] Review of staging and diagnosis of malignant pleural mesothelioma
    Jordan, Sean
    Nitsche, Lindsay
    Yendamuri, Sai
    AME SURGICAL JOURNAL, 2022, 2
  • [10] Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma
    Schneider, Marc A.
    Muley, Thomas
    Kahn, Nicolas C.
    Warth, Arne
    Thomas, Michael
    Herth, Felix J. F.
    Dienemann, Hendrik
    Meister, Michael
    ONCOTARGET, 2016, 7 (44) : 71285 - 71297